Ali M Alsamil

Utrecht University - Utrecht / Netherlands

Natural Sciences / Molecular Biology & Genetics

AD Scientific Index ID: 5369118

Universiteit Utrecht

Registration, Add Profile,
Premium Membership

Print Your Certificate

Ali M Alsamil's MOST POPULAR ARTICLES

1-) Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature reviewAM Alsamil, TJ Giezen, TC Egberts, HG Leufkens, AG Vulto, ...European Journal of Pharmaceutical Sciences 154, 105501, 2020122020

2-) Type and extent of information on (Potentially critical) quality attributes described in european public assessment reports for adalimumab biosimilarsAM Alsamil, TJ Giezen, TC Egberts, HG Leufkens, H GardarsdottirPharmaceuticals 14 (3), 189, 202162021

3-) Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case studyAM Alsamil, TJ Giezen, TC Egberts, HG Leufkens, H GardarsdottirBiologicals 69, 30-37, 202132021

4-) Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019AM Alsamil, H Gardarsdottir, HG Leufkens, TC Egberts, TJ GiezenDrug Discovery Today, 103725, 202322023

5-) Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilarsAM Alsamil, TJ Giezen, TC Egberts, E Doevendans, HG Leufkens, ...European Journal of Pharmaceutical Sciences 175, 106227, 202212022

ARTICLES

Add your articles